Life WhispererLife WhispererLife WhispererLife Whisperer
  • Home
  • Products
    • Life Whisperer Genetics
    • Life Whisperer Viability
    • Life Whisperer Genetics
    • Life Whisperer Oocytes
    • Life Whisperer Endometrial Receptivity
  • Distribution
  • News & Science
    • Press
    • IVF-X
    • Publications
  • About
  • Request a Trial
  • Home
  • Products
    • Life Whisperer Embryo Quality
    • Life Whisperer Viability
    • Life Whisperer Genetics
    • Life Whisperer Oocytes
    • Life Whisperer Endometrial Receptivity
  • Distribution
  • News & Science
    • Press
    • IVF-X
    • Publications
  • About
  • Request a Trial
  • Home
  • Products
    • Life Whisperer Genetics
    • Life Whisperer Viability
    • Life Whisperer Genetics
    • Life Whisperer Oocytes
    • Life Whisperer Endometrial Receptivity
  • Distribution
  • News & Science
    • Press
    • IVF-X
    • Publications
  • About
  • Request a Trial

New study shows that Artificial Intelligence can help women find good quality eggs to support IVF and egg freezing

AI Healthcare company Presagen, in collaboration with Ovation Fertility (USA) and California Fertility Partners (USA), presented a recent study of Life Whisperer at the American Society for Reproductive Medicine (ASRM) 2022 Scientific Congress, Oct 2022.

Life Whisperer uses Artificial Intelligence to support IVF treatment procedures and female fertility.

Life Whisperer has developed a new AI algorithm that was able to non-invasively assess the quality of a woman’s eggs, or oocytes, by assessing images of the egg. The AI was able to predict which eggs were likely to develop into a usable embryo for an existing or future IVF treatment.

This study suggests that, in the future, AI could potentially be used to help doctors and patients make better informed choices about additional IVF cycles and oocyte freezing, which is important given the high cost of these procedures and ongoing storage, and given the patients’ reliance on these frozen oocytes for future family building.

Other applications for the AI include informing the likelihood of success for donor eggs, selecting the highest quality eggs for fertilization, and, importantly, providing reassurance of the likelihood of IVF success to the patient.

The study also found that seemingly high-quality oocytes do not always develop into blastocysts, which suggests that other factors beyond oocyte quality are important contributors to embryo development, such as male infertility factors. Life Whisperer had previously developed its own unique patented algorithm that could identify these cases in a dataset used to train the AI, which was critical for ensuring that the AI performed accurately.

Download the poster here.

Life Whisperer

Life Whisperer is a world-leader in the application of AI in IVF. The Life Whisperer Viability and Genetics AI-based embryo assessment tools are the first to be commercialized in a series of applications that encompass the complete IVF journey. Life Whisperer aims to improve IVF success rates at every point and, as a result, reduce time-to-pregnancy, making IVF more affordable and accessible to patients globally. Life Whisperer is being used in IVF clinics around the world.

Presagen

Presagen is an AI healthcare company that is changing the way clinics, patients, and medical data from around the world are connected through AI. Its platform, The Social Network for Healthcare, connects clinics and patients globally, and enables collaboration and data sharing to create scalable AI healthcare products that are affordable and accessible for all. The decentralized network democratizes the creation of AI products, promotes collaboration through incentives, and protects data privacy and ownership. With a focus on improving Women’s Health outcomes globally, Presagen’s first product, Life Whisperer, is being used by IVF clinics globally to improve pregnancy outcomes for couples struggling with fertility. With a vision of creating the largest network of clinics, patients, and medical data from around the world, Presagen is driving the future of AI Enhanced Healthcare.

Connect with us
Share
0

Related posts

September 4, 2023

Life Whisperer AI featured in three oral presentations at the Asia Pacific fertility conference, ASPIRE 2023


Read more
August 22, 2023

Presagen sponsors Women’s Health Innovation Summit (WHIS) USA to support the future health of woman-kind


Read more
August 16, 2023

Can analysis of embryo appearance using artificial intelligence provide insight into the sex of your baby, and help prevent male bias in IVF?


Read more
August 8, 2023

Independent study shows Life Whisperer’s AI can predict the viability of embryos that have previously been frozen


Read more

Comments are closed.

HIPAA and GDPR compliant and ISO 13485 certified.

CE Logo

Life Whisperer Viability and Genetics are commercially available in Australia, Canada, Europe (EEA), UK, Japan, India, UAE, Hong Kong, Israel, Malaysia, Thailand, Vietnam, Singapore, New Zealand, Turkey, Trinidad & Tobago, and Guyana (not available in the USA).

Life Whisperer Genetics is commercially available in the USA.

For sale to healthcare professionals only.

© Life Whisperer Diagnostics Pty Ltd     Terms and conditions   |   Privacy Policy   |   Fair Use Policy
  • Home
  • Products
  • Distribution
  • News & Science
  • About
  • Request a Trial